Azole Antifungal Lozenges for Oral Candidiasis: Mechanism, Efficacy, and Emerging Resistance

Read full text Summarise with VIRAT
Authors: Prajakta Shinde P, P.P. Kale, Kedar R. Rajapure, Krishna A. Shahane, Prathamesh P. Hase
Cited by: 0
References: 77

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Lozenges are an effective pharmaceutical form for delivering medications to treat conditions affecting the mouth and throat. These solid preparations dissolve slowly, providing both local and systemic effects. First conceptualized by James Lofthouse in 1865, lozenges have evolved into a convenient remedy for infections, coughs, and sore throats. Their advantages include prolonged drug action, ease of administration, and improved absorption, though they may cause inconsistent drug distribution and accidental swallowing. Commonly, lozenges incorporate agents such as antibiotics, antifungals, and anesthetics. Notably, miconazole and clotrimazole azole-based antifungal agents—are widely used to treat oral candidiasis, a fungal infection primarily caused by Candida albicans. Miconazole disrupts fungal cell membranes, while clotrimazole shows high efficacy in immunocompromised individuals, such as HIV patients or those undergoing chemotherapy. However, antifungal resistance is a growing concern, driven by genetic mutations, structural alterations, and increased drug efflux in fungal cells. To counteract this, researchers are exploring advanced drug delivery systems like bioadhesive lozenges, which extend drug contact time within the oral cavity, improving therapeutic outcomes while minimizing systemic exposure.

Fields of Study & Subjects

Antifungal resistance and susceptibility Advanced Drug Delivery Systems HIV/AIDS oral health manifestations

Publication details

Journal / source
International Journal of Science Strategic Management and Technology
Volume
02
Issue
03
Pages
1–9
Publication date
30 March 2026
Language
EN